T. Rowe Price Associates’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $585K | Buy |
|
|||||
|
2025
Q2 | $590K | Buy |
|
|||||
|
2025
Q1 | $680K | Buy |
|
|||||
|
2024
Q4 | $715K | Sell |
|
|||||
|
2024
Q3 | $1.57M | Buy |
|
|||||
|
2024
Q2 | $1.29M | Buy |
|
|||||
|
2024
Q1 | $1.21M | Sell |
|
|||||
|
2023
Q4 | $1.37M | Buy |
|
|||||
|
2023
Q3 | $1.18M | Sell |
|
|||||
|
2023
Q2 | $2.05M | Sell |
|
|||||
|
2023
Q1 | $3.43M | Sell |
|
|||||
|
2022
Q4 | $3.42M | Sell |
|
|||||
|
2022
Q3 | $2.77M | Sell |
|
|||||
|
2022
Q2 | $3.74M | Buy |
|
|||||
|
2022
Q1 | $4.57M | Buy |
|
|||||
|
2021
Q4 | $4.64M | Sell |
|
|||||
|
2021
Q3 | $67.4M | Sell |
|
|||||
|
2021
Q2 | $90M | Sell |
|
|||||
|
2021
Q1 | $141M | Sell |
|
|||||
|
2020
Q4 | $160M | Sell |
|
|||||
|
2020
Q3 | $118M | Sell |
|
|||||
|
2020
Q2 | $119M | Sell |
|
|||||
|
2020
Q1 | $117M | Sell |
|
|||||
|
2019
Q4 | $157M | Buy |
|
|||||
|
2019
Q3 | $171M | Sell |
|
|||||
|
2019
Q2 | $215M | Sell |
|
|||||
|
2019
Q1 | $211M | Sell |
|
|||||
|
2018
Q4 | $224M | Buy |
|
|||||
|
2018
Q3 | $336M | Buy |
|
|||||
|
2018
Q2 | $278M | Sell |
|
|||||
|
2018
Q1 | $226M | Sell |
|
|||||
|
2017
Q4 | $242M | Sell |
|
|||||
|
2017
Q3 | $237M | Sell |
|
|||||
|
2017
Q2 | $212M | Sell |
|
|||||
|
2017
Q1 | $214M | Sell |
|
|||||
|
2016
Q4 | $211M | Sell |
|
|||||
|
2016
Q3 | $202M | Sell |
|
|||||
|
2016
Q2 | $192M | Buy |
|
|||||
|
2016
Q1 | $164M | Buy |
|
|||||
|
2015
Q4 | $190M | Buy |
|
|||||
|
2015
Q3 | $125M | Buy |
|
|||||
|
2015
Q2 | $174M | Buy |
|
|||||
|
2015
Q1 | $164M | Buy |
|
|||||
|
2014
Q4 | $145M | Buy |
|